Cancer Immunotherapy Market, Valued at $125.68 Billion in 2025, Sees $194.64 Billion Opportunity by 2029 - Dominated by Amgen, AstraZeneca, Roche, Bayer, and Eli Lilly
28 janv. 2025 11h29 HE
|
Research and Markets
Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Market Report 2025" has been added to ResearchAndMarkets.com's offering.This Cancer Immunotherapy market report covers market...
Asia-Pacific Cell and Gene Therapy Manufacturing QC Market Research 2024-2033: Robust Growth Fueled by Disease Prevalence and Therapy Approvals, AI and Real-time Testing Trends Set to Shape Future
16 janv. 2025 07h41 HE
|
Research and Markets
Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Cell and Gene Therapy Manufacturing QC Market: Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's...
Cell Therapy Technologies Market Forecasts 2024-2029: Advancements in Gene Editing Technologies, Development of Automated Cell Processing Systems and Regulatory Support for Fast-tracking Therapies
16 janv. 2025 04h43 HE
|
Research and Markets
Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "Cell Therapy Technologies Market by Product (Media, Sera & Reagents, Vessels, Single-Use Equipment), Process (Cell Processing, Preservation,...
Cancer Immunotherapy Global Market Overview 2023-2030, Competitive Analysis of Amgen, AstraZeneca,Bayer, BMS, Eli Lilly, F. Hoffmann-La Roche, GSK, Immunocore, J&J, Merck, Novartis, Pfizer
10 janv. 2025 04h06 HE
|
Research and Markets
Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The global market for Cancer Immunotherapy...
Rapid Rise of Synthetic Biology Fuels Enzymatic DNA Synthesis Boom Across Biopharma and Genomics
09 janv. 2025 11h38 HE
|
Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Enzymatic DNA Synthesis Market by Service, by Application, by End-User, and By Region" report has been added to ResearchAndMarkets.com's offering.The...
CAR-T Cell Therapy Market Research 2024-2025: Navigating the CAR-T Landscape, Major Players, Recent Approvals, and Pioneering Therapies
03 janv. 2025 04h09 HE
|
Research and Markets
Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "CAR-T Cell Therapy Market - Market Size, Forecasts, Trials, and Trends, 2025" report has been added to ResearchAndMarkets.com's offering. This...
Cancer Immunotherapy Market Research Report 2025-2029: Curing Cancer is Generating Enormous New Markets - How Big Are They? Where is the Opportunity?
26 déc. 2024 04h13 HE
|
Research and Markets
Dublin, Dec. 26, 2024 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Market 2025-2029 - Forecasts for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer, with Executive and Consultant...
Allogeneic T Cell Therapies Market Report, 2024-2028 & 2033 - Valued at $1.16 Billion in 2024, the Industry is Forecast to Generate Revenues of $1.69 Billion by 2028
12 déc. 2024 05h38 HE
|
Research and Markets
Dublin, Dec. 12, 2024 (GLOBE NEWSWIRE) -- The "Allogeneic T Cell Therapies Market, 2024-2028 & 2033" report has been added to ResearchAndMarkets.com's offering. The allogeneic T cell...
Immuno-Oncology Strategic Industry Research Report 2023-2024 & 2030: Approval of Pembrolizumab (Keytruda) and Nivolumab (Opdivo), which Target PD-1 and PD-L1 Pathways have Set New Benchmarks
05 déc. 2024 10h16 HE
|
Research and Markets
Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Immuno-Oncology - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Immuno-Oncology...
Cancer Immunotherapy Strategic Research Business Report 2023-2030: Improved Delivery Systems, Desire for Non-Toxic Treatments, Checkpoint Inhibitors Spur New Developments and Growth
04 déc. 2024 10h55 HE
|
Research and Markets
Dublin, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Cancer...